Results
73,241 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Wunsch Scott MCEO, Logistics |  SRTAStrata Critical Medical, Inc.Grant or award | A | — 57.2K sh | Oct 30, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Wunsch Scott MCEO, Logistics | SRTAStrata Critical Medical, Inc. Grant or award | A | — 57.2K sh | Oct 30, 2026 |
| 13 | Charters WilliamDirector |  RGSREGIS CORPGrant or award | A | — 2,857 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 13 | Siegfried Erin FreundChief Legal Counsel /Corp Sec |  NWBINorthwest Bancshares, Inc.Tax withholding | F | $26K 1,708 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 13 | Hardy AndrewEVP, Chief Sales Officer |  NXPINXP Semiconductors N.V.Option exercise | M | — 1,080 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 13 | Valenzuela Rionda Jose PedroDirector |  SCCOSOUTHERN COPPER CORP/Grant or award | A | — 400 sh | Oct 30, 2026 traded Oct 30, 2026 |
| 13 | Scheiwer Mark JEVP, CFO & CAO |  SMGSCOTTS MIRACLE-GRO COGrant or award | A | — 2,163 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 13 | Wunsch Scott MCEO, Logistics | SRTAStrata Critical Medical, Inc. Grant or award | A | — 57.2K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 13 | PAEPER HOLLY BethDirector |  LFUSLITTELFUSE INC /DEGrant or award | A | $25K 62 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 12 | Grimme ArneDirector |  NBISNebius Group N.V.Open-market purchase · 10b5-1 plan | BUY | $25K 148 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 12 | Hardy AndrewEVP, Chief Sales Officer | NXPINXP Semiconductors N.V. Tax withholding | F | $139K 550 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 12 | Betz WilliamEVP & CFO | NXPINXP Semiconductors N.V. Tax withholding | F | $107K 423 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 12 | Sanders DaxPresident |  KMIKINDER MORGAN, INC.Gift | G | — 1,600 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 11 | Hancock MarkDirector, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $214K 4,280 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 11 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $95K 1,904 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 10 | Glazer David A.See Remarks |  PLTRPalantir Technologies Inc.Grant or award | A | — 211.2K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 10 | Dandekar AtulCSBO |  MAZEMaze Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $241K 7,500 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner |  ACTUACTUATE THERAPEUTICS, INC.Grant or award | A | — 48.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Gillman Joan HDirector |  IDCCInterDigital, Inc.Grant or award | A | — 49 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Rankin Jean FDirector | IDCCInterDigital, Inc. Grant or award | A | — 2 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 133.1K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 682.9K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 87.7K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | vant Hoff GrahamDirector |  ANNAAleAnna, Inc.Option exercise | M | — 20.2K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 82.5K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 269.3K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 36.1K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 133.1K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 65.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Hutcheson Stewart DDirector | IDCCInterDigital, Inc. Grant or award | A | — 47 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Kritzmacher John ADirector | IDCCInterDigital, Inc. Grant or award | A | — 2 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Martino Roxanne MDirector |  VTRVentas, Inc.Grant or award | A | $1,500 18 sh | Oct 30, 2026 traded Oct 30, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 36.1K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Brezski RichardChief Financial Officer | IDCCInterDigital, Inc. Grant or award | A | — 31 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 682.9K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 82.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 65.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Jacobs Kevin JSee Remarks |  HLTHilton Worldwide Holdings Inc.Option exercise | M | — 28.5K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 9 | Jacobs Kevin JSee Remarks | HLTHilton Worldwide Holdings Inc. Option exercise | M | — 27.4K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 9 | Jacobs Kevin JSee Remarks | HLTHilton Worldwide Holdings Inc. Option exercise | M | — 29.1K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 9 | Jacobs Kevin JSee Remarks | HLTHilton Worldwide Holdings Inc. Option exercise | M | — 31.1K sh | Oct 30, 2026 traded Oct 29, 2026 |